This boundary is adjacent to the TADs containing the cancer genes CDKN2A, CDKN2B, and MTAP, all of which are tumor suppressors, and this boundary is located within a fragile site region (FRA9C) (31). This evidence concerns the gene CDKN2B and cancer.